Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Inventory (2020 - 2025)

Historic Inventory for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to $41.4 million.

  • Treace Medical Concepts' Inventory fell 501.48% to $41.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.4 million, marking a year-over-year decrease of 501.48%. This contributed to the annual value of $39.3 million for FY2024, which is 3422.81% up from last year.
  • According to the latest figures from Q3 2025, Treace Medical Concepts' Inventory is $41.4 million, which was down 501.48% from $42.4 million recorded in Q2 2025.
  • In the past 5 years, Treace Medical Concepts' Inventory ranged from a high of $43.6 million in Q3 2024 and a low of $7.4 million during Q1 2021
  • In the last 5 years, Treace Medical Concepts' Inventory had a median value of $26.1 million in 2023 and averaged $25.5 million.
  • Per our database at Business Quant, Treace Medical Concepts' Inventory soared by 10265.48% in 2023 and then tumbled by 501.48% in 2025.
  • Treace Medical Concepts' Inventory (Quarter) stood at $10.6 million in 2021, then surged by 83.03% to $19.3 million in 2022, then soared by 51.29% to $29.2 million in 2023, then surged by 34.23% to $39.3 million in 2024, then rose by 5.53% to $41.4 million in 2025.
  • Its Inventory stands at $41.4 million for Q3 2025, versus $42.4 million for Q2 2025 and $37.9 million for Q1 2025.